158 results
8-K
EX-99.1
ACET
Adicet Bio Inc
14 May 24
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
4:03pm
, business operations, employee hiring and retention, and
ability to raise additional capital; Adicet’s ability to execute on its strategy including
DEFR14A
ACET
Adicet Bio Inc
26 Apr 24
Revised proxy
4:13pm
Scientific Strategy (Infectious Disease, Respiratory & Immunology) from January 2013 to August 2013 and Senior Vice President of Late Stage … , Dr. Aftab was responsible for research strategy and execution of Atara’s preclinical science and translational medicine activities. Prior to that, Dr
8-K
ACET
Adicet Bio Inc
22 Apr 24
Regulation FD Disclosure
4:31pm
studies, business operations, employee hiring and retention, and ability to raise additional capital; Adicet's ability to execute on its strategy
8-K
EX-99.1
q05d qm0k8l
22 Apr 24
Regulation FD Disclosure
4:31pm
PRE 14A
m5971nq9d
12 Apr 24
Preliminary proxy
5:23pm
424B5
7of6 0hb8
22 Mar 24
Prospectus supplement for primary offering
4:12pm
8-K
EX-99.1
z8zd7zr4 6e
19 Mar 24
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
4:13pm
424B5
mtpozlgi
24 Jan 24
Prospectus supplement for primary offering
4:32pm
424B5
vpupq uyy
22 Jan 24
Prospectus supplement for primary offering
4:30pm
8-K
EX-99.1
cya86ke4l80
16 Jan 24
Regulation FD Disclosure
7:01am
8-K
enthk4b10a0 ohjud
4 Jan 24
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
7:17am
8-K
EX-99.1
ci06xx1q2hpj43ci i5i
4 Jan 24
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
7:17am
8-K
EX-99.1
qhia0f c57smfh3j2vg
8 Nov 23
Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates
4:12pm
8-K
EX-99.1
pfh3gri604siz0
9 Aug 23
Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:17pm
8-K
EX-99.1
8x98ic y6pb
11 Jul 23
Adicet Announces Appointment of Katie Peng to the Board of Directors
8:32am